Table 3.
Patient clinical characteristics
| Characteristic | Patient M (SD) / N (%) |
|---|---|
| Cancer diagnoses | |
| Lung | 5 (22.7%) |
| Cervical | 1 (4.5%) |
| Ovarian | 3 (13.6%) |
| Uterine | 2 (9.1%) |
| Vulvar | 1 (4.5%) |
| Lymphoma | 4 (18.2%) |
| Other | 2 (18.2%) |
| Missing | 2 (9.1%) |
| Cancer stage (current) | |
| Stage II | 1 (4.5%) |
| Stage III | 1 (4.5%) |
| Stage IV | 16 (72.7%) |
| Metastasis indicated | |
| Yes | 12 (54.5%) |
| No | 9 (40.9%) |
| Missing | 1 (4.5%) |
| Chemotherapy | |
| Yes | 14 (63.6%) |
| No | 8 (36.4%) |
| Radiation therapy | |
| Yes | 0 (0.0%) |
| No | 22 (100.0%) |
| Immunotherapy | |
| Yes | 2 (9.1%) |
| No | 20 (90.9%) |
| Targeted therapy | |
| Yes | 1 (4.5%) |
| No | 21 (95.5%) |
| Karnofsky Performance Score | 9.00 (1.58) |
| ECOG Performance Score | 1.41 (2.27) |
Note: All information taken from medical record
M = Mean, SD = standard deviation, ECOG = Eastern Cooperative Oncology Group